Parker Waichman LLP

DePuy’s Chief Exec Testifies on Knowledge of ASR Hip Implant During Trial’s Fourth Day

Marketing Roll-Out of The Failed DePuy Orthopaedics ASR Hip Implant. The man who oversaw the marketing roll-out of the failed DePuy Orthopaedics ASR metal-on-metal hip implant assailed to the company’sop position by 2011. On Wednesday, his videotaped testimony was being played before jurors as his company attempts to defend itself against the first of thousands of […]

ASR Hip Implant

Marketing Roll-Out of The Failed DePuy Orthopaedics ASR Hip Implant. The man who oversaw the marketing roll-out of the failed DePuy Orthopaedics ASR metal-on-metal hip implant assailed to the company’sop position by 2011.

On Wednesday, his videotaped testimony was being played before jurors as his company attempts to defend itself against the first of thousands of claims that he and others at DePuy hid evidence from the public that the ASR hip implant was defective.

Johnson & Johnson appointed Andrew Ekdahl in 2011 to head its DePuy Orthopaedics division after the company stumbled over the previous five years, largely due to the problems caused by the ASR metal-on-metal hip implant. Ekdahl, according to a New York Times report, had been in charge of marketing at DePuy and that included the introduction and continuous misdirections that eventually led to the device’s recall in August 2010.

Ekdahl’s videotaped testimony was played during the fourth day of a trial involving the first claim against the ASR

Ekdahl’s videotaped testimony was played during the fourth day of a trial involving the first claim against the ASR hip implant to reach a jury. The case is being heard in Los Angeles Superior Court but has gained national attention as tens of thousands of victims and other recipients of this specific hip implant in the U.S. await the result.

Many have already filed injury claims against DePuy after they were forced to endure months of severe pain and a costly revision surgery to remove the failed hip implant. Thousands more are likely to experience these same complications. Previous testimony delivered in this trial shows that executives at DePuy, including Ekdahl, were aware that the ASR hip implant would fail early (within five years) for at least 40 percent of its recipients.

Based on the testimony played for jurors on Wednesday, Ekdahl’s level of deception related to the ASR hip implant goes beyond that one internal study which detailed the early failure rate.

New York Times reports that jurors heard Ekdahl being pressed by attorneys representing Loren Kransky, a 65-year-old victim of a failed DePuy ASR hip implant, to admit that the device was recalled in August 2010 because “it did not meet the clinical standards we wanted in the marketplace.” Prior to that testimony, including the months leading to the recall, Ekdahl had publicly stated that the ASR was doing very well on the market, even as reports of its failures had begun to accumulate.

Ekdahl also testified that he was placed in charge of the introduction of the ASR device in 2005

Ekdahl also testified that he was placed in charge of the introduction of the ASR device in 2005, when it was released in the U.S., and was a topmarketing executive at DePuy as the failed hip implant was given to more than 90,000 recipients in this country alone and tens of thousands more around the world.

During this time, according to previous testimony in this case, executives at DePuy were being made aware of internal tests that showed its ASR device was under-performing other devices on the market and was hearing from surgeons who reported widespread complications in patients who received it.

People who received an ASR metal-on-metal hip implant were likely to have the cup component fail to fuse to their hip bone, leading to pain and inflammation and cause the implant to fall out of place. Recipients were forced to endure painful revision surgeries to either correct or remove the device.

The ASR hip implant also shed toxic amounts of metallic ions into a recipient’s bloodstream, leading to tissue and organ damage, especially at the site of the implant.

More marketing executives with DePuy are expected to be called to testify as the trial continues this week in Los Angeles, according to The Times report.

The man who oversaw the marketing roll-out of the failed DePuy Orthopaedics ASR metal-on-metal hip implant

The man who oversaw the marketing roll-out of the failed DePuy Orthopaedics ASR metal-on-metal hip implant assailed to the company’s top position by 2011.

On Wednesday, his videotaped testimony was being played before jurors as his company attempts to defend itself against the first of thousands of claims that he and others at DePuy hid evidence from the public that the ASR hip implant was defective.

Johnson & Johnson appointed Andrew Ekdahl in 2011 to head its DePuy Orthopaedics division after the company stumbled over the previous five years, largely due to the problems caused by the ASR metal-on-metal hip implant. Ekdahl, according to a New York Times report, had been in charge of marketing at DePuy and that included the introduction and continuous misdirections that eventually led to the device’s recall in August 2010.

Ekdahl’s videotaped testimony was played during the fourth day of a trial

Ekdahl’s videotaped testimony was played during the fourth day of a trial involving the first claim against the ASR hip implant to reach a jury. The case is being heard in Los Angeles Superior Court but has gained national attention as tens of thousands of victims and other recipients of this specific hip implant in the U.S. await the result.

Many have already filed injury claims against DePuy after they were forced to endure months of severe pain and a costly revision surgery to remove the failed hip implant. Thousands more are likely to experience these same complications. Previous testimony delivered in this trial shows that executives at DePuy, including Ekdahl, were aware that the ASR hip implant would fail early (within five years) for at least 40 percent of its recipients.

Based on the testimony played for jurors on Wednesday, Ekdahl’s level of deception related to the ASR hip implant goes beyond that one internal study which detailed the early failure rate. New York Times reports that jurors heard Ekdahl being pressed by attorneys representing Loren Kransky, a 65-year-old victim of a failed DePuy ASR hip implant, to admit that the device was recalled in August 2010 because “it did not meet the clinical standards we wanted in the marketplace.”

Prior to that testimony, including the months leading to the recall, Ekdahl had publicly stated that the ASR was doing very well on the market, even as reports of its failures had begun to accumulate.

Ekdahl also testified that he was placed in charge of the introduction of the ASR device in 2005, when it was released in the U.S., and was a topmarketing executive at DePuy as the failed hip implant was given to more than 90,000 recipients in this country alone and tens of thousands more around the world.

During this time, according to previous testimony in this case

During this time, according to previous testimony in this case, executives at DePuy were being made aware of internal tests that showed its ASR device was under-performing other devices on the market and was hearing from surgeons who reported widespread complications in patients who received it.

People who received an ASR metal-on-metal hip implant were likely to have the cup component fail to fuse to their hip bone, leading to pain and inflammation and cause the implant to fall out of place. Recipients were forced to endure painful revision surgeries to either correct or remove the device. The ASR hip implant also shed toxic amounts of metallic ions into a recipient’s bloodstream, leading to tissue and organ damage, especially at the site of the implant.

More marketing executives with DePuy are expected to be called to testify as the trial continues this week in Los Angeles, according to The Times report.

Need Legal Help Regarding ASR Hip Implant?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

[sc name=”post-footers”]

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I have no words to express how grateful I am for the service of the Parker Waichman firm. Thanks to Michelle Josama and Jorge Peniche for all their attention.
Miguela Quezada
a month ago
5 Star Reviews 150
Thanks to Jorge Peniche and Parker Waichman who were always aware of my case and that it was resolved in the best way without you I don't know what I would do, thank you
Jhonatan Romerozavaleta
a year ago
5 Star Reviews 150
Parker Waichman handled the case for my dad who had bed sores.The team was very professional.The paralegal Michele Josama who was assigned to the case was an absolute pleasure to deal with.She was always so helpful in every way.Her patience and kindness was outstanding.Michael Zaransky the attorney on the case was very attentive to all our requests and delivered a result that we were very pleased with.Parker Waichman will certainly be recommended to anyone I know that needs legal assistance!!
richard nissenbaum
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038